Eledon Pharmaceuticals (ELDN) Shareholder's Equity (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.79% |
| Dec 31, 2025 | 129.31% |
| Sep 30, 2025 | -29.75% |
| Jun 30, 2025 | -14.52% |
| Mar 31, 2025 | -5.70% |
| Dec 31, 2024 | 206.65% |
| Sep 30, 2024 | 131.72% |
| Jun 30, 2024 | 8.84% |
| Mar 31, 2024 | -45.24% |
| Dec 31, 2023 | -236.21% |
| Sep 30, 2023 | -18.67% |
| Jun 30, 2023 | -41.48% |
| Mar 31, 2023 | 214.41% |
| Dec 31, 2022 | -83.14% |
| Sep 30, 2022 | -5.55% |
| Jun 30, 2022 | -4.44% |
| Mar 31, 2022 | -4.68% |
| Dec 31, 2021 | -3.95% |
| Sep 30, 2021 | -4.35% |
| Jun 30, 2021 | -2.91% |
| Mar 31, 2021 | -3.53% |
| Dec 31, 2020 | 786.25% |
| Sep 30, 2020 | 129.86% |
| Jun 30, 2020 | -20.34% |
| Mar 31, 2020 | 24.09% |
| Dec 31, 2019 | -29.19% |
| Sep 30, 2019 | -16.63% |
| Jun 30, 2019 | 61.47% |
| Mar 31, 2019 | -31.49% |
| Dec 31, 2018 | -20.92% |
| Sep 30, 2018 | -14.82% |
| Jun 30, 2018 | -11.46% |
| Mar 31, 2018 | 24.91% |
| Dec 31, 2017 | -5.66% |
| Sep 30, 2017 | -12.03% |
| Jun 30, 2017 | 0.32% |
| Mar 31, 2017 | 964.69% |
| Dec 31, 2016 | -108.93% |
| Sep 30, 2016 | -22.19% |
| Jun 30, 2016 | -24.36% |
| Mar 31, 2016 | 1,747.84% |
| Dec 31, 2015 | -96.13% |
| Sep 30, 2015 | -13.11% |
| Jun 30, 2015 | -8.96% |
| Mar 31, 2015 | -12.18% |
| Dec 31, 2014 | 1.86% |